ERVK-9 Antibody (C-Term)
Purified Rabbit Polyclonal Antibody (Pab)
- 产品详情
- 实验流程
- 背景知识
Application ![]()
| WB, E |
---|---|
Primary Accession | Q9UKH3 |
Other Accession | Q902F9, O71037, P61565, P61566, Q69384, P61567, Q902F8, P63135 |
Reactivity | Human |
Predicted | Human |
Host | Rabbit |
Clonality | polyclonal |
Isotype | Rabbit IgG |
Calculated MW | 79016 Da |
Other Names | Endogenous retrovirus group K member 9 Env polyprotein, EnvK4 protein, Envelope polyprotein, HERV-K(C6) envelope protein, HERV-K109 envelope protein, HERV-K_6q14.1 provirus ancestral Env polyprotein, Surface protein, SU, Transmembrane protein, TM, ERVK-9 |
---|---|
Target/Specificity | This ERVK-9 antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 636-669 amino acids from human ERVK-9. |
Dilution | WB~~1:2000 E~~Use at an assay dependent concentration. |
Format | Purified polyclonal antibody supplied in PBS with 0.05% (V/V) Proclin 300. This antibody is purified through a protein A column, followed by peptide affinity purification. |
Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
Precautions | ERVK-9 Antibody (C-Term) is for research use only and not for use in diagnostic or therapeutic procedures. |
Name | ERVK-9 |
---|---|
Function | Retroviral envelope proteins mediate receptor recognition and membrane fusion during early infection. Endogenous envelope proteins may have kept, lost or modified their original function during evolution. This endogenous envelope protein has lost its original fusogenic properties. |
Cellular Location | [Transmembrane protein]: Cell membrane; Single-pass type I membrane protein [Endogenous retrovirus group K member 9 Env polyprotein]: Virion |
For Research Use Only. Not For Use In Diagnostic Procedures.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
Retroviral envelope proteins mediate receptor recognition and membrane fusion during early infection. Endogenous envelope proteins may have kept, lost or modified their original function during evolution. This endogenous envelope protein has lost its original fusogenic properties.
REFERENCES
Barbulescu M.,et al.Curr. Biol. 9:861-868(1999).
de Parseval N.,et al.J. Virol. 77:10414-10422(2003).
Blaise S.,et al.Proc. Natl. Acad. Sci. U.S.A. 100:13013-13018(2003).
Wang-Johanning F.,et al.Oncogene 22:1528-1535(2003).

终于等到您。ABCEPTA(百远生物)抗体产品。
点击下方“我要评价 ”按钮提交您的反馈信息,您的反馈和评价是我们最宝贵的财富之一,
我们将在1-3个工作日内处理您的反馈信息。
如有疑问,联系:0512-88856768 tech-china@abcepta.com.